Clinical Trial Update: O6-Benzylguanine-Mediated Tumor Sensitization With Chemoprotected Autologous Stem Cell in Treating Patients With Malignant Gliomas [Phase 1, Phase 2]

View source ↗

Summary

Early-phase trial investigating O6-Benzylguanine–mediated tumor sensitization with chemoprotected autologous stem cell therapy in malignant gliomas; the study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Gliosarcoma

Drugs mentioned

• O6-Benzylguanine (O6-Benzylguanine)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Glioblastoma, Gliosarcoma | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2018-12-28